Enhancing Cancer Treatment: Heyou Hospital's Adoption of RayStation Technology in China
In a significant milestone for advanced cancer care, Heyou Hospital in Foshan City, Guangdong Province, China, has officially selected the RayStation treatment planning system from RaySearch Laboratories AB. This decision marks a notable expansion in the hospital's technological capabilities, especially in the field of particle therapy. The total value of this order amounts to RMB 51 million (approximately SEK 77 million), with RMB 18 million recognized in the first quarter of 2025, making it RaySearch's third-largest order to date.
Heyou Hospital is renowned for its comprehensive and personalized healthcare solutions, focusing particularly on oncology, neurology, orthopedics, and neurosurgery. This institution is on the cutting edge of medical technology, previously acquiring a combined Hitachi carbon ion and proton machine in 2021. The integration of RayStation will enhance their capabilities by equipping them to conduct treatment planning not just for particle therapy, but also traditional photon treatments.
What Is Ion Beam Therapy?
Ion beam therapy represents the pinnacle of external radiotherapy methods. Unlike conventional radiotherapy, which uses photons, ion beam therapy employs protons or carbon ions to target tumors. This advanced technique allows for precise control over the energy deposition within the tumor, minimizing radiation exposure to surrounding healthy tissues and significantly reducing side effects associated with treatment.
The rapid growth of the market for particle treatments—such as proton and carbon ion therapies—within China positions RaySearch as a leader in treatment planning systems for these technologies. This latest order with Heyou Hospital fortifies their leadership status in this burgeoning field.
Advanced Technologies Boosting Patient Care
RayStation will provide Heyou Hospital with a suite of advanced technologies that can revolutionize patient treatment protocols. These innovations include:
- - Pencil Beam Scanning: Allowing for finer targeting of tumors.
- - Robust Optimization: Ensuring treatment plans are adaptable under various uncertainties.
- - Linear Energy Transfer Optimization: Tailoring energy distribution for efficiency.
- - Proton Arc Optimization: Maximizing the effectiveness of proton treatments.
- - GPU Accelerated Dose Calculations: Facilitating faster and more precise calculations.
- - Adaptive Replanning Support: Enabling ongoing modifications to treatment based on patient progress and responses.
The integration of these technologies into Heyou Hospital’s arsenal represents a leap forward in providing high-quality patient care in radiation therapy.
Statement from Leadership
Johan Löf, the founder and CEO of RaySearch, expressed his enthusiasm regarding the partnership, stating, "I am pleased to announce our collaboration with Heyou Hospital and the significant order for RayStation. I look forward to deepening our relationship and to a fruitful cooperation in advanced radiation therapy." His comments reflect both the optimism surrounding technological collaboration and the shared goal of improving patient outcomes through refined treatment methodologies.
The implications of this partnership extend beyond immediate treatment advantages. They represent a transformative step towards more comprehensive and personalized care for cancer patients, highlighting Heyou Hospital's commitment to adopting the latest advances in medical technology.
In summary, the selection of RayStation by Heyou Hospital not only underscores the institution's dedication to exceptional healthcare but also situates them at the forefront of a rapidly evolving market poised to redefine cancer treatment standards. As the healthcare landscape in China continues to adapt to technological advancements, collaborations such as this are critical to enhancing therapeutic efficacy and patient care across the nation.